Treat the first bid on a distressed data asset as a floor and insist on an open auction
In the 23andMe sale (customer genetic data and the business around it) a three-day auction with seven bidders started at $52 million, Regeneron won it at $256 million, and TTAM then took the business at $305 million in a final round, nearly six times the opening bid; the court records that the price was $302.5 million in cash. Hilco, which ran the Rite Aid intangibles sale (brand, website and customer loyalty data), says the single-transaction price of $7.8 million was 'multiple times higher' than the values in the earlier investment-bank-led process.
Dated 19 Oct 2026Source checked 19 Oct 2026Page out of reach at the last check, 21 Oct 2026Basis: strong
In the source's own words
“The Debtors held a three-day auction beginning on May 14, with seven bidders participating and an opening bid of $52 million (Walper Decl. ¶ 13).”
Where it was read
Also read from the same source
- Substantially all assets of 23andMe Holding Co. (direct-to-consumer genetic testing business, about 13 million customers, genetic and other personal data, medical research programme), sold to TTAM Research Institute in Chapter 11 under section 363. The price is for the whole business, not the data alone.
- Substantially all assets of 23andMe Holding Co. (about 13 million customers' genetic and other personal data, laboratory, brand), Regeneron Pharmaceuticals' bid that won the three-day May 2025 auction (seven bidders, opening bid $52 million) and was later topped
- At the June 2025 sale hearing 23andMe had about 13 million customers, and more than 80% of them had chosen to take part in its medical-research programmes.
- In re 23andMe Holding Co.: memorandum opinion approving the sale to TTAM Research Institute (June 27, 2025) (In re 23andMe Holding Co., et al., No. 25-40976-357 (Bankr. E.D. Mo.), Memorandum Opinion, ECF No. 908 (June 27, 2025))
- In re 23andMe Holding Co.: section 363(b)(1) does not let a debtor ignore state data-transfer laws (June 27, 2025) (In re 23andMe Holding Co., et al., No. 25-40976-357 (Bankr. E.D. Mo.), Memorandum Opinion, ECF No. 908 (June 27, 2025))
- In re 23andMe Holding Co.: which privacy policy counts under section 363(b)(1) (June 27, 2025) (In re 23andMe Holding Co., et al., No. 25-40976-357 (Bankr. E.D. Mo.), Memorandum Opinion, ECF No. 908 (June 27, 2025))
Figures it counts in
It is shown on its own, not counted into a figure.